ProQR Therapeutics (PRQR) Payables (2013 - 2026)
ProQR Therapeutics (PRQR) posted Payables of $221270.9 for Q1 2026, down 36.21% sequentially from $346885.0 in Q4 2025, and down 49.19% YoY from $435480.2 in Q1 2025.
ProQR Therapeutics (PRQR) Payables (2013 - 2026) Analysis & Trends
ProQR Therapeutics has reported Payables for 14 years, with the latest figure at $221270.9 in Q1 2026.
- Quarterly Payables fell 49.19% year-over-year to $221270.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $221270.9 (down 49.19% YoY) and the FY2025 annual result came in at $346885.0, up 1928.86% from the prior year.
- Payables declined to $221270.9 in Q1 2026 per PRQR's latest filing, from $346885.0 in the prior quarter.
- Over five years, Payables peaked at $1.7 million in Q4 2023 and troughed at $17097.5 in Q4 2024.
- A 5-year average of $473039.6 and a median of $356561.8 in 2025 frame the typical range for Payables.
- The sharpest annual moves came in 2022 and 2024: Payables surged 278695.49% in 2022, then plunged 98.97% in 2024.
- Over 5 years, Payables stood at $399937.0 in 2022, then jumped by 314.57% to $1.7 million in 2023, then slumped by 98.97% to $17097.5 in 2024, then jumped by 1928.86% to $346885.0 in 2025, then sank by 36.21% to $221270.9 in 2026.
- According to Business Quant data, Payables over the past three periods registered $221270.9, $346885.0, and $356561.8 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - | 221,270.93 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 221,270.93 |
| Dec 31, 2025 | 346,884.97 |
| Sep 30, 2025 | 356,561.80 |
| Jun 30, 2025 | 1.45 Mn |
| Mar 31, 2025 | 435,480.16 |
| Dec 31, 2024 | 17,097.53 |
| Sep 30, 2024 | 34,044.80 |
| Jun 30, 2024 | 35,537.29 |
| Mar 31, 2024 | 359,585.74 |
| Dec 31, 2023 | 1.66 Mn |
| Sep 30, 2023 | 127,365.09 |
| Jun 30, 2023 | 129,582.00 |
| Mar 31, 2023 | 296,242.34 |
| Dec 31, 2022 | 399,936.97 |
| Sep 30, 2022 | 428,516.59 |
| Jun 30, 2022 | 818,432.48 |
| Mar 31, 2022 | 924,806.28 |
| Dec 31, 2021 | 5.68 Mn |
| Sep 30, 2021 | 1.05 Mn |
| Jun 30, 2021 | 332,378.92 |